Valvular & structural heart disease

Patient characteristics and long-term outcomes in patients undergoing transcatheter aortic valve implantation in a failed surgical prosthesis vs in a native valve: A Danish nationwide study

Am Heart JPublished Retrospective cohort study

Authors' conclusion

TAVI in a failed surgical aortic prosthesis as compared to TAVI in a native valve, was not associated with significantly different short- and long-term mortality

Study context

Population
All Danish citizens undergoing TAVI, January 1, 2008 to December 31, 2020median age 81
Participants
6,070 participants
Exposure
Valve-in-valve TAVI vs native-valve TAVI
  • Valve-in-valve-TAVIn = 247
Outcome
Risk of death
Follow-up
30 days and 5 years
Methodological detailsnationwide registries
  • Nationwide registries

Main finding

As reported in the abstract

Cumulative risk of death

Valve-in-valve-TAVI

30-day death
2.4% (95% CI: 1.0%-5.0%)
5-year death
42.5% (95% CI: 34.2%-50.6%)

Native-valve-TAVI

30-day death
2.7% (95% CI: 2.3%-3.1%)
5-year death
44.8% (95% CI: 43.2%-46.4%)

30-day death

Valve-in-valve-TAVI2.4% (95% CI: 1.0%-5.0%)
Native-valve-TAVI2.7% (95% CI: 2.3%-3.1%)

5-year death

Valve-in-valve-TAVI42.5% (95% CI: 34.2%-50.6%)
Native-valve-TAVI44.8% (95% CI: 43.2%-46.4%)
Valve-in-valve-TAVI vs Native-valve-TAVIHazard ratio (95% CI)
Death at 30 days; multivariable Cox
0.95(0.41–2.19)
Death at 5 years; multivariable Cox
0.79(0.62–1.00)

Observational data: associations, not effects.

Further findings

Patient characteristics

Valve-in-valve-TAVI patients younger but greater burden of CV comorbidities vs native-valve-TAVI

Safety

Pacemaker implantation · within 30 days

Original publication

Patient characteristics and long-term outcomes in patients undergoing transcatheter aortic valve implantation in a failed surgical prosthesis vs in a native valve: A Danish nationwide study. Am Heart J. Published 11 May 2023. doi:10.1016/j.ahj.2023.05.007

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.